Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.7 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.
Unternehmens-codePGNY
Name des UnternehmensProgyny Inc
IPO-datumOct 25, 2019
Gegründet am2008
CEOMr. Peter (Pete) Anevski
Anzahl der mitarbeiter675
WertpapierartOrdinary Share
GeschäftsjahresendeOct 25
Addresse1359 Broadway
StadtNEW YORK
BörseNASDAQ Global Select Consolidated
LandUnited States of America
Postleitzahl10018
Telefon12128883124
Websitehttps://www.progyny.com/
Unternehmens-codePGNY
IPO-datumOct 25, 2019
Gegründet am2008
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten